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Abstract-The generation and gender effects on the joint distributions of total plasma 
cholesterol (Total-C), In triglycerides (InTrig), HDL-cholesterol (HDL-C), LDL-choles- 
terol (LDL-C), apolipoproteins AI (APO AI), AI1 (Apo AII), and E (1nApo E) were 
studied in 184 male grandparents (MGP), 242 female grandparents (FGP), 237 male 
parents (MP), 235 female parents (FP), 202 male children (MC), and 200 female children 
(FC). Homogeneity of variance tests revealed that lipid variances were gender and/or 
generation specific while apolipoprotein variances were homogeneous across strata. In 
the absence of heterogeneity of variance, significant heterogeneity in LDL:lnTrig and 
1nTrig:Apo AI1 covariation was found between genders in the parental generation. In 
the presence of heterogeneity of variance, significant heterogeneity of correlation 
between genders and/or across generations was found for the HDL-C : LDL-C, Total- 
C : LDL-C, Total-C: InTrig, 1nTrig: LDL-C, Total-C : 1nApo E and HDL-C : 1nApo E 
bivariate distributions. Analyses of principal components revealed that the generation 
and gender specific cohorts have similar eigenvalues but distinct eigenvectors for the first 
two principal components underlying the seven dimensional lipid and apolipoprotein 
distribution. We conclude that the amount of variability explained by the first two 
principal components is the same across cohorts but how the interindividual variability 
is distributed among the lipid and apolipoprotein traits is generation and gender specific. 
This study documents the role that variance and covariance might play in determining 
risk of disease for special subgroups of the population at large. It also demonstrates how 
variances and covariances between risk factors traits characterize life processes of aging 
and sexual dimorphism. This study argues that future biometrical genetic and epi- 
demiological studies of coronary artery disease must take into account age and gender 
effects on interindividual variability and covariability of risk factors. 
Cholesterol Triglyceride HDL-cholesterol Apolipoprotein-AI 
Apolipoprotein-AI1 Apolipoprotein-E 
INTRODUCTION the general population is associated with levels 
of risk factors in the normal range of variability 
Discrete genetic lesions, such as familial hyper- [3,4]. In the majority of cases, an individual’s 
cholesterolemia [ 1,2], explain only a small frac- risk of developing CAD is the consequence 
tion of the cases of coronary artery disease of complex interactions among the effects of 
(CAD) that aggregate in families. Most CAD in many genetic and environmental factors [5]. 
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Quantitative levels of risk factors for CAD that 
are measures of lipid metabolism and hemosta- 
sis are determined by these interactions. Most 
investigations of genetic and environmental 
causes of the development of CAD in the popu- 
lation at large have focused on separate analyses 
of interindividual differences in levels of each of 
these continuously varying traits [6,7]. Separate 
univariate analyses do not take advantage of 
the information about CAD risk that is pro- 
vided by knowing interindividual differences in 
the relationship between measures of lipid 
metabolism and hemostasis that define a multi- 
variate profile. Just as the discretely defined 
hyperlipidemias may be distinguished by a well 
defined relationship between the traits of lipid 
metabolism [8], we hypothesize that a significant 
fraction of the variation in risk of CAD among 
individuals in the general population may be 
associated with variations in the relationships 
between otherwise normal levels of risk factor 
traits. In other words, heterogeneity of covari- 
ability between risk factor traits among sub- 
groups of the population may contribute to 
determining interindividual differences in risk 
for CAD. 
In general, studies of the multivariate distri- 
bution of risk factor traits are necessary for 
establishing how the effects of genetic and en- 
vironmental variation combine to determine 
risk of CAD. Specifically, the predictive value of 
genetic variability at a particular gene locus 
involved in lipid metabolism will be enhanced 
by considering its effects on interindividual 
differences in the relationships between traits 
that measure lipid metabolism. For example, 
in addition to affecting trait levels, inherited 
variation of the apolipoprotein E molecule is 
associated with profound differences in the mag- 
nitude and direction of the correlation between 
total cholesterol, betalipoprotein, and triglycer- 
ide levels [9]. Although the hyperlipidemias are 
characterized by a well defined relationship be- 
tween triats, little is known about the relation- 
ship between covariability among these risk 
factor traits in the so-called normal range and 
risk of CAD in the population at large. Because 
of the importance of the relationships between 
biological risk factor traits that each have a 
genetic component, it seems obvious that our 
understanding of the link between genes and 
CAD endpoints will be enhanced by the consid- 
erations of the effects of genetic variation on the 
interindividual differences in the relationship 
between levels of such traits. 
This paper reports our studies to determine 
effects of generation and gender on interindivid- 
ual variability and covariability in the lipid 
metabolism profile defined by plasma levels of 
total cholesterol, triglycerides, HDL cholesterol, 
LDL cholesterol, and the apolipoproteins AI, 
AII, and E. In addition, we report the effects of 
differences in phenotypic variability among gen- 
eration and gender specific cohorts on the ob- 
served correlations between these traits. Since 
age and gender are strongly associated with risk 
of CAD, this information of the generation and 
gender specific differences in the variability and 
covariability among risk factor traits provides a 
necessary first step towards relating such covari- 
ability to risk of CAD in the general population. 
In a subsequent paper we will evaluate the 
impact of genetic variability on the multivariate 
profiles of the age and gender specific cohorts 
reported here. 
SAMPLE 
As part of the Rochester Family Heart Study 
(RFHS), 276 multigeneration pedigrees were 
ascertained through elementary school children. 
The RFHS sample includes a total of 2002 
individuals. Moll et al. [lo] give details of the 
sampling methods that were used. To investi- 
gate the heterogeneity in means, variances, and 
covariances of lipid metabolites among gender 
and generation groups we stratified the sample 
into six cohorts-grandfathers, grandmothers, 
fathers, mothers, male children and female chil- 
dren. Within-cohort covariability due to genetic 
relatedness was removed by considering only 
one individual from each set of related individ- 
uals within any one cohort. Two individuals not 
measured for age and height were also excluded. 
Women taking hormones were not excluded 
since this study focuses on characterizing the 
multivariate profiles of cohorts representative 
of the population at large. Future studies 
will examine the effects of exogenous hor- 
mones, lipid lowering drugs, and other environ- 
mental factors on interindividual lipid and 
apolipoprotein variability and covariability. 
Statistical inferences about the distribution of 
lipid traits in the six generation and gender 
secific cohorts rely on the assumption of multi- 
variate normality. In order to reduce skewness 
we removed individuals with total cholesterol 
(Total-C), In triglyceride (InTrig), HDL-choles- 
terol (HDL-C), LDL-cholesterol (LDL-C), 
apolipoprotein AI (APO AI), AI1 (APO AII), 
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and In E (InApo E) values more than 2 
standard deviations from their generation 
and gender specific means. Eight individuals 
were removed prior to invoking the truncation 
criterion because they have extreme outlier 
values of triglyceride and/or apolipoprotein 
E (i.e. triglyceride levels > 1900 mg/ml and/or 
Apo E levels > 20 mg/dl which are at least 5 
standard deviations from the overall sample 
mean). In addition, triglyceride and Apo E 
distributions were transformed before the trun- 
cation procedure since these distributions were 
extremely skewed (g, > 1.5) and leptokurtotic 
(g, > 2.5). After considering logarithmic trans- 
formation and a variety of power transfor- 
mations we decided that to be consistent with the 
literature the natural logarithm (log, = In) was 
the most appropriate transformation. The 1nTrig 
and 1nApo E distributions showed a marked 
reduction in skew (g, < 0.58) and kurtosis 
(gZ < 0.68) which was reduced further by the 
truncation procedure. 
After removal of outliers by the truncation 
procedure described above, the cohorts of unre- 
lated persons considered in this study include a 
total of 1300 individuals-184 male grand- 
parents (MGP), 242 female grandparents (FGP), 
237 male parents (MP), 235 female parents (FP), 
202 male children (MC), and 200 female children 
(FC). The number of women taking hormones 
(17 FC, 6 FP, and 5 FGP) is small compared to 
the number not taking hormones and indicates 
that our sample is more characteristic of females 
not taking exogeneous hormones. Summary 
statistics for age, height, weight, and body mass 
index ([kg/cm21 x 1000) in these six cohorts are 
presented in Table 1. Since the RFHS sample 
represents a cross section of the Rochester, 
Minnesota population, there was some age over- 
lap between generations which can be seen by 
examining the minimum and maximum age 
values. The average age ranged from 15.23 
(years) for male children to 68.75 (years) for 
MGPs. Age overlap between generation specific 
cohorts involved less than 10% of the total 
number of individuals. The height, weight, and 
body mass index (BMI) distributions among 
these cohorts were representative of other North 
American populations [l 11. In general, the males 
were taller, weighted more, and had larger BMIs 
than females in the same generation. Specifically, 
the mean height and weight of MGPs were 
significantly (p c 0.05) larger and the variance 
of BMI was significantly smaller than for FGPs. 
In the parental generation, males had signifi- 
cantly larger age, height. weight, and BMI means 
than females. However, variability of age and 
height of MPs was significantly smaller. In 
children, males were significantly taller, variabil- 
ity of height and weight significantly greater and 
variability of BMI significantly smaller than 
females. 
LABORATORY METHODS 
All blood samples were collected in EDTA 
by venipuncture. Total plasma cholesterol 
and triglyceride levels were measured by stan- 
dard enzymatic methods (Beckman kits) 
[ 12,131. HDL-C was measured following pre- 
cipitation of Apo B containing lipoproteins with 
polyethylene glycol [14]. LDL-C was calculated 
using the modified Freidenwald formula (LDL- 
C = TC - (HDL-C + 0.16 Tg)) [15]. Aliquots of 
plasma were frozen at -70°C for apolipo- 
protein determinations. Levels of Apo AI, AII, 







Male Female means variance 
Age (yr) GP” 68.75 67.77 7.65 
P 43.62 41.58 6.89 
C 15.23 15.39 5.08 
Height (cm) GP 174.33 160.62 6.13 
P 177.80 164.92 6.18 
C 162.49 158.30 18.00 
Weight (kg) GP 83.46 69.07 13.23 
P 85.60 68.93 12.77 
C 55.62 53.20 17.95 
BMI (kg/cm2 x 1000) GP 2.74 2.68 0.40 
P 2.71 2.54 0.36 
C 2.04 2.08 0.35 
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and E were measured in 6 replicates of each 
sample using radioimmunoassays developed 
and standardized in the Mayo Atherosclerosis 
Research Laboratory [ 16-181. This included the 
use of quality control plasmas to correct for day 
to day variability in the assays as well as the use 
of primary pure apolipoprotein standards as 
described [16, 181. 
STATISTICAL METHODS 
The goal of the statistical analyses in this 
study was to estimate and test hypotheses about 
the heterogeneity of variances and covariances 
among the six generation-gender specific co- 
horts. Forward stepwise regression [19] was 
used to select the set of concomitants which 
removed the maximum amout of variability in 
each truncated lipid and apolipoprotein variable 
within each cohort. The independent variables 
used in the forward stepwise regression include 
age, age*, age3, height, height*, height3, weight, 
weight’, weight3, BMI, BMI*, and BM13. Using 
an alpha level of 0.05 as the cut point for 
inclusion, the variables which were selected be- 
cause they made a significant contribution in at 
least one of the cohorts for at least one the lipid 
or apolipoprotein traits were age, age*, height, 
height*, weight, weight*, BMI, and BMI*. In 
instances where BMI or BMI* contributed sig- 
nificantly to be regression we found that weight, 
weight*, height and height* did not contribute 
significantly. Although this variable selection 
procedure does not focus on the identification of 
which subset of variables plays an important 
role in which cohort, it provides a method for 
removing the maximum amount of variability 
due to concomitant variability within cohorts. A 
multiple regression equation including the set 
of selected independent variables was used to 
adjust each of the biological traits separately for 
each gender in each of the three generations. 
The residuals from this regression equation were 
used in all subsequent analyses. 
Statistical inferences about homogeneity of 
variance and covariance among cohorts rely on 
the assumption of normality. To verify that each 
of the truncated, adjusted, and transformed 
lipid and apolipoprotein variables was normally 
distributed the Lilliefor’s test for normality 
was performed [20]. The null hypothesis of 
normality was accepted for all 42 cohort-specific 
variables at the p > 0.10 significance level. 
Appropriate statistics exist for testing the 
equality of symmetric variance-covariance 
matrices. We employed one that utilizes the 
generalized variances (i.e. the determinant of the 
variance-covariance matrix) in the Bartlett’s 
homogeneity of variance test statistic [21]. 
Statistical theory does not exist for testing 
homogeneity of covariance between two traits 
without also considering the magnitude of the 
trait variance. In order to detect heterogeneity 
of trait variance that may be underlying hetero- 
geneity of the variance-covariance matrices, we 
used the univariate Bartlett’s test statistic [21]. 
When there was evidence for heterogeneity 
of trait variance across strata we tested for 
homogeneity of the Pearson product-moment 
correlations as a measure of the covari- 
ante-variance interaction which can give rise to 
differences among cohorts [22]. The tests for 
homogeneity of variance, variance-covariance, 
and correlation coefficients were constructed 
using the MATRIX programming language 
available from SAS [23]. 
A substantial fraction of the variances and 
covariances in the 21 bivariate distributions 
was significantly heterogeneous across cohorts. 
This result suggested to us that trivariate, 
tetravariate, etc. tests for homogeneity of vari- 
ance-covariance matrices would be inappropri- 
ate. Principal component analyses using the 
correlation matrices provided a method to 
examine the internal dependency structure 
underlying the multivariate (seven dimensional) 
distribution [24]. The correlation matrices were 
used for these analyses because of scale differ- 
ences between variables (i.e. logarithm trans- 
formed variables vs untransformed variables). 
To determine if the variation explained by the 
first two principal components was equivalent 
across strata, we tested for homogeneity of the 
eigenvalues using the following test statistic: 
M = 1/2Cni(lO& Aj - [C?Zi log, n/Zni])’ 
where ni is the sample size of the ith cohort and 
li is the eigenvalue of the ith cohort. This test 
statistic is approximately distributed as a chi- 
square distribution with k - 1 @where k is the 
number of cohorts [24]. 
RESULTS 
Biological interpretations of the eflects of age and 
gender on lipid metabolism 
Plasma lipoprotein metabolism depends on 
a complex metabolic pathway which involves 
many gene product mediated reactions which 
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transport and catabolize the lipid components 
of lipoprotein particles for distribution to per- 
ipheral tissues and excretion. Metabolic path- 
ways, such as lipoprotein metabolism, are 
known to be under homeostatic control [25-311. 
These homeostatic control mechanisms regulate 
steady state levels of metabolites, the variance in 
metabolite concentrations, and the covariation 
between traits levels [25-27,30,31]. Since the 
strength and sensitivity of these control mechan- 
isms is effected by genetic and environmental 
factors, the homeostatic properties of metabolic 
systems are expected to be different across gen- 
ders and generations [25,28-301. The modu- 
lation of lipoprotein levels through sex hormone 
levels is one example of the metabolic sexual 
dimorphism which results from the genotypic 
difference between males and females [32-351. 
The weakening of the homeostatic controls in 
many metabolic systems during senescence is 
one example of the changes in metabolic control 
which occur during the life history of an individ- 
ual or population [30,36-411. Research in plant 
and animal genetics has found evidence that 
generation and gender differences in phenotypic 
variation (or covariation) is attributable to 
differences in genetic, gene by environment 
interaction, and/or environmental variation 
(or covariation) [42-481. To stimulate further 
interest in the biological significance of the 
second moments of phenotypic distributions we 
have discussed the results from this study in 
terms of the role of homeostasis in explaining 
epidemiological observations. 
Contribution of age, height, weight, and BMI to 
trait variability 
The amount of trait variation attributable 
to variation in concomitants ranged from 
1.83% for LDL-C in MGPs to 22.47% for 
1nTrig in FPs. There were substantial differ- 
ences across cohorts in both the total amount 
of interindividual variation explained and the 
relative contribution of each of the concomi- 
tants (data not shown). The contribution of 
concomitants to Total-C, HDL-C, and LDL-C 
variability was the greatest in MC and FPs 
whereas the contribution to 1nTrig variability 
was the greatest in MPs and FPs. Among the 
apolipoprotein distributions, the contribution 
of concomitants was greatest in the MC and FC. 
Lipid levels 
The gender and generation specific mean lipid 
levels (Table 2) ranged from 148.77-214.70 
(mg/dl) for Total-C, 4.43-4.95 (lnmg/dl) for 
InTrig, 40.39-51.38 (mg/dl) for HDL-C, and 
88.99-140.55 (mg/dl) for LDL-C. The range of 
mean levels we observed were characteristic of 
other age and gender specific cohorts from 
North American populations [l 1,511. Overall, 
children had the lowest mean levels, grand- 
parents had the highest mean levels, and parents 
had intermediate mean levels of these lipids. The 
only exception to this trend was the lower than 
expected HDL-C levels in MGPs and MPs. 
Traditional tests for the equality of means 
across strata (univariate and multivariate) were 
not performed because the statistical assump- 
tion of homogeneity of variance underlying 
those tests were violated. 
Lipid variances 
In Table 3, we present the generation and 
gender specific variances, covariances, and 
correlations for adjusted lipid levels. The 
lipid variances ranged from 389.8 to 1167.9 
for Total-C, 0.09 to 0.14 for InTrig, 53.00 to 
Table 2. Mean levels for lipids and apolipoproteins across gender and generation 
Total-C (mg/dl) 
















Males Females Males Females 
294.85 214.70 Apo AI (mg/dl) GP” 134.76 149.26 
191.38 179.37 : 130.66 140.74 
148.81 148.77 127.7 128.35 
4.95 4.89 Apo AI1 (mg/dl) GP 33.04 34.77 
4.83 4.52 P 34.03 34.36 
4.43 4.43 C 32.73 32.76 
41.41 5 1.38 InApo E (In-mg/dl) GP 1.70 1.77 
40.39 50.59 P 1.53 1.48 




“GP = grandparent, P = parent, C = child. 
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106.02 for HDL-C, and 401.35 to 969.42 for 
LDL-C. Results from the homogeneity of 
variance tests across generations and between 
genders are presented in Table 4(A). Total-C 
variation was generation dependent in males 
and females and gender dependent in parents. 
1nTrig variation was generation dependent in 
males only. HDL-C variation was generation 
dependent in males and gender dependent in 
children and parents. LDL-C variation was 
generation dependent in males and females. 
Significant differences in variance across gener- 
ations were attributable to an increase in vari- 
ance with increasing age. The significant 
difference between genders was attributable to 
increased Total-C variance and decreased HDL- 
C variance in males when compared to females 
in the same generation. 
From a biological point of view, the observed 
generation effect on variance may indicated that 
the homeostatic control mechanisms are weak- 
ening with age resulting in increased deviation 
from the mean value. The observed gender 
effects on variance may indicate that influences 
of sexual dimorphism are more pronounced in 
the parent generation than in the child and 
grandparent generation. 
From a risk prediction point of view, the 
generation and gender effects on lipid variances 
provide additional information on the fraction 
of individuals in each cohort which exceed a 
particular high risk threshold value. If the null 
hypothesis (H,) of homogeneity of variance 
were true, then cohort differences in the fraction 
of individuals at high risk would be attributable 
to differences in mean levels only. On the other 
hand, if the alternative hypothesis (H,) is 
demonstrated, then cohort differences in the 
proportion of individuals at high risk is the 
consequence of differences in both mean and 
variance. In Fig. 1 we have illustrated the 
impact of means and variances (pooled and 
cohort specific) on the fraction of individuals in 
each cohort that exceed the standard high risk 
thresholds for Total-C and HDL-C. In both 
examples, the means plus or minus 3 standard 
deviations are plotted for each cohort under the 
null hypothesis (H,) and the alternative hypoth- 
esis (H,). In Fig. l(a), a threshold of 240 mg/dl 
Total-C was used to discriminate between indi- 
viduals at high and low risk. We calculated 
under the alternative hypothesis (H,) that 
14.5% of the MGP, 23.0% of the FGP, 5.7% 
of the MP, and 0.8% of the FP will be at high 
risk of CAD. Under the null hypothesis (H,), 
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Table 4. Homogeneity of variance, variance-covariance matrices and correlation coefficients 
among lipids across gender and generation 
(A) Homogeneity of variance 
df Total-C 1nTrig HDL-C LDL-C 





MGP = FGP 
MP=FP 
MC=FC 
5 99.20** 16.53** 46.76*’ 74.74** 
2 32.64** 11.80** 17.87** 34.24** 
2 64.61** 4.44 4.82 40.45’2 
1 0.21 0.01 1.55 0.02 
1 8.57** 0.01 19.14** 0.10 
1 2.84 1.44 7.76** 0.07 
(B) Homogeneity of bivariate variance-covariance matrices (X*-values) where superscript b and c denote tests of correlation 
coefficients 
Null hypotheses 
MGP=FGP=MP=FP=MC=FC 15 142.21**c 
MGP=MP=MC 6 47.16**c 
FGP=FP=FC 6 88.77**b 
MGP = FGP 3 2.67 
MP=FP 3 23.62**b 


































*p < 0.05; **p < 0.01. 
“MGP = male grandparent, FGP = female grandparent, MP = male parent, FP = female parent, FC = female child, 
MC = male child. 
bHeterogeneity of the vector of correlation coefficients, p < 0.05. 
cHomogeneity of the vector of correlation coefficients, p > 0.05. 
the fraction of individuals crossing the risk 
threshold is overestimated in children and 
female parents and underestimated in male 
parents and grandparents. In Fig. l(b), a 
threshold of 30 mg/dl HDL-C was used to 
discriminate between individuals at high and 
low risk. We calculated under the alternative 
hypothesis (H,) that 11.3% of MGP, 1.9% of 
FGP, 7.9% of MP, 1.8% of FP, 1.6% of MC, 
and 2.9% of FC will be at high risk of CAD. 
Under the null hypothesis (H,), the proportion 
of individuals crossing the risk threshold is 
overestimated in children and male parents and 
underestimated in female parents and grand- 
parents. These figures illustrate one method for 
using the information provided by means and 
variances to characterize the relationship be- 
tween lipid levels and risk of CAD. If a gradu- 
ated risk curve were known for these cohorts, 
then a Taylor series expansion about the mean 
of the cohorts would provide a good estimate 
of the fraction of individuals at risk of CAD. 
Other measures, such as the covariation be- 
tween traits, should enhance the precision of the 
estimates of the proportion of individuals which 
are in different risk categories. 
Lipid covariances and correlations 
For any metabolic system, its steady state or 
homeostatic set point is determined by the 
covariation or correlation between the traits in 
the system. For normally distributed physiologi- 
cal traits, individuals in the population may 
exist in any one of five types of physiological 
states-the normal state, the compensated hy- 
perfunctional state, the compensated hypofunc- 
tional state, the uncompensated hyperfunctional 
state, and the uncompensated hypofunctional 
state [30]. These different physiological states 
are expected have different risks of disease. For 
this reason we have examined the covariances 
and correlations among lipid traits in each 
cohort and tested for differences across gener- 
ation and gender. 
In cases where we had already noted sig- 
nificant heterogeneity of variance, tests for 
homogeneity of variancecovariance matrices 
are uninformative. We therefore relied on tests 
of the homogeneity of correlation coefficients 
across strata to reveal which members of the 
subset of bivariate distributions were generation 
and/or gender specific [Table 4(B)]. Given the 
results from the the tests for homogeneity of 
variance four types of outcomes are reported in 
Table 4(B): 
(i) homogeneity of variance and homogen- 
eity of variancecovariance matrices, 
(ii) homogeneity of variance and heterogen- 
eity of variancecovariance matrices, 
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Fig. 1. (a) Total-C means f 3 SD and risk threshold @-&,-pooled variance: H,-cohort specific variance). 
(b) HDL-C means f 3 SD and risk threshold (HO-pooled variance: H,-cohort specific variance). 
(iii) heterogeneity of variance and homogen- 
eity of correlation, and 
(iv) heterogeneity of variance and heterogen- 
eity of correlated. 
We emphasize that the test statistics for the 
homogeneity of correlation coefficients have 
greater power to detected a given difference 
between correlation estimates when the values 
being compared are large, say (r > OS), 
than when the correlations are small, say 
r CO.5 
There were only two instances where hom- 
ogeneity of variance (type (i) and (ii) outcomes) 
allowed us to make definite inferences about 
covariance differences between the lipid levels. 
First, MGPs and FGPs had homogeneous 
covariances between all of their lipid levels 
(type (i) outcome). Second, male and female 
parents showed significant differences in their 
1nTrig : LDL-C covariation (type (ii) outcome). 
The corresponding Pearson product-moment 
correlation coefficients (Table 3) of I = 0.202 
for MPs and r = 0.669 for FPs also illus- 
trate the gender differences in lnTrig:LDL-C 
covariation. 
In instances where heterogeneity of variance 
was demonstrated, the tests for homogeneity 
of the correlation coefficients indicated that 
Total-C : HDL-C and 1nTrig : HDL-C corre- 
lations were similar across all strata (type 
(iii) outcome). The weighted average Total- 
C : HDL-C and 1nTrig : HDL-C correlations 
were r = 0.156 and r = -0.410, respectively. 
On the other hand, we observed heterogeneity 
of correlations (type (iv) outcome) in the Total- 
C : LDL-C, Total-C : InTrig, HDL-C : LDL-C, 
and 1nTrig : LDL-C bivariate distributions 
across generations in females and between 
genders in the parental generation. Across 
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generations, we found that FPs had signifi- 
cantly stronger correlations for HDL-C : LDL-C 
(FP:r = -0.399 > FGP:r = -0.034, FC:r = 
- 0.285), Total-C:lnTrig (FP:r = 0.553 > 
FGP : 0.363, FC : r = 0.133), and 1nTrig : LDL-C 
(FP: r = 0.669 > FGP: r = 0.268, Fc: r = 0.355) 
than female grandparents and children. In con- 
trast, FGPs had significantly larger correlation 
between Total-C: LDL-C (FGP: r = 0.953 > 
FP:r =0.912, FC:r =0.866) than female 
parents and children but these differences in 
correlation are relatively small and probably not 
biologically relevant. 
Between genders, in the parent generation, 
the significant heterogeneity in correlation co- 
efficients was attributable to stronger corre- 
lations in females for HDL-C: LDL-C (FP:r = 
0.399 < MP : r = 0.022) and Total-C : 1nTrig 
(FP:r = 0.553 > MP:r = 0.354) and a stronger 
Total-C: LDL-C correlation in males (MP: r = 
0.962 > FP: r = 0.912). In the child generation, 
only the Total-C: LDL-C correlation was sig- 
nificantly different across gender (MC : r = 
0.947 > FC: r = 0.866). In general, the stat- 
istically significant differences in the Total- 
C: LDL-C correlations across cohorts may not 
be biologically relevant because the actual 
differences in correlation are small. 
180 mg/dl LDL-C, it is evident that a greater 
proportion of MPs are in the HDL-C and 
LDL-C medium risk range than FPs because of 
the lack of correlation. However, if males had a 
strongly negative HDL-C : LDL-C correlation, 
like the females, then a much greater proportion 
of the MP cohort would cross into the high risk 
domain. In Fig. 2(b), the 95% confidence el- 
lipses for 1nTrig and LDL-C levels in MPs 
and FPs also show that means, variances, and 
covariances combine to determine differences 
in fraction of individuals at risk. Using risk 
thresholds of 5.25 In mg/dl 1nTrig and 180 mg/dl 
LDL-C, there is a greater fraction of MPs in the 
medium and high risk ranges than FPs. How- 
ever, in contrast to the HDL-C:LDL-C 
example, this figure illustrates that the inter- 
action between means, variances, and covari- 
antes predicts that some proportion of the FP 
cohort will be in the high risk category. 
Apolipoprotein levels 
From a biological perspective, the generation 
effects on lipid covariances and correlations 
indicate that either the genetic covariances or 
environmental covariances between lipid traits 
must be changing with age. Consequently, the 
distribution of individuals within each of the 
five possible physiological states-normal, com- 
pensating or uncompensating hyperfunction- 
ing or hypofunctioning-is shifting with age. 
The gender effects on the lipid covariance and 
correlations also provides evidence that the 
genetic or environmental covariances are sexual 
dimorphic. 
The AI, AII, and E apolipoproteins have 
distinct functions in lipoprotein metabolism. 
The Apo AI and AI1 are cofactors of lecithin- 
acyl transferase in HDL particles [49]. The Apo 
E is a protein component of chylomicron, 
VLDL, and some HDL particles and functions 
as a ligand for the lipoprotein uptake by the 
liver and peripheral tissues with E-receptor and 
B-E receptors [50]. The mean levels of Apo AI, 
AII, and E presented in Table 2 range from 
127.70-149.26 (mg/dl) for Apo AI, 32.73-34.77 
(mg/dl) for Apo AII, and 1.38-l .77 (In mg/dl) 
for 1nApo E. Apo AI and 1nApo E mean levels 
were lowest in the children, intermediate in the 
parents, and highest in the grandparents. Apo 
AI1 mean levels were highest in the FGPs and 
FPs and lowest in the MC. 
Apolipoprotein variances 
From a risk assessment point of view, Since apolipoproteins are gene products 
knowledge about the covariances or corre- which mediate the catabolism of lipoprotein 
lations enables one to partition the bivariate particles, variability in their levels must be 
space defined by combinations of risk factors controlled by gene regulation [25,27-301. 
into high, medium and low risk categories. In Differences in variance across generation or 
Fig. 2 we illustrate that gender differences in gender could imply differences in the homeo- 
HDL-C : LDL-C and 1nTrig : LDL-C covari- static control of gene regulation in response to 
ation is associated with differences in the pro- aging or gender specific metabolic processes. 
portion of individuals at risk of CAD. In The cohort specific variances, covariances, and 
Fig. 2(a), the 95% confidence ellipses for correlations for the apolipoprotein variables 
HDL-C and LDL-C levels in MPs and FPs are presented in Table 5. The apolipoprotein 
show mean, variances, and covariance differ- variances ranged from 163.62-309.77 for Apo 
ences across genders and their impact on risk. AI, 12.15-15.74 for Apo AII, and 0.11-0.13 
Using risk thresholds of 30 mg/dl HDL-C and for 1nApo E. In contrast to the substantial 
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Fig. 2. (a) Ninety-five percent confidence ellipses for HDL-C and LDL-C levels in male and female parents. 
(b) Ninety-five percent confidence ellipses for 1nTrig and LDL-C levels in male and female parents. 
heterogeneity of variance noted for the lipid 
distributions among cohorts, tests for the hom- 
ogeneity of variance (Table 6) revealed that only 
Apo AI variability was significantly different 
across generations in males and between gen- 
ders in the parental generation. The significant 
effect of generation in males was associated with 
increasing variability in Apo AI levels with 
increasing age. The significant effect of gender in 
the parental generation was attributable to 
larger variability in Apo AI levels in females 
than in males. 
From a biological point of view, the gener- 
ation and gender effect on Apo AI variances but 
not Apo AI1 or 1nApo E variances may be a 
consequence of differences in the regulation of 
Apo AI, Apo AII, and Apo E genes. These 
results may also indicate that the homeostatic 
control of Apo AI gene expression weakens with 
age in males but not females and is different in 
male and female parents. The homogeneity of 
Apo AI1 and 1nApo E variance across cohorts 
does not imply that the proportion of variation 
explained by genetic and environmental factors 
are the same across cohorts. It only implies that 
the total phenotypic variation is constant. 
Apolipoprotein covariances and correlations 
The covariation and correlation between 
apolipoproteins (Table 5) was also more homo- 
geneous across cohorts than the covariation and 
correlation among lipids traits. Heterogeneity 
in the Apo AII: 1nApo E variance-covariance 
matrices across all six cohorts, in the absence 
of evidence for heterogeneity of variance, was 
the only exception (Table 6). This hetero- 
geneity of covariance was not substantial 
enough to significantly affect the correlation 
coefficients. Tests for the homogeneity of corre- 
lation coefficients indicated that all correlations, 
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Table 5. Apolipoprotein variances (diagonal elements), covariances (elements of upper triangle) and correlations (elements 
of lower triangle) 
Apo AI Apo AI1 InApo E 
Males Females Males Females Males Females 
Apo AI GP” 309.77 259.93 33.02 24.28 0.08 0.39 
P 188.19 24944 20.97 24.48 -0.11 0.16 
C 163.62 191.29 18.97 20.50 0.65 0.49 
Apo AI1 GP 0.473** 0.410** 15.74 13.49 0.04 -0.04 
P 0.404** 0.445** 14.32 12.15 0.02 0.13 
C 0.400** 0.423** 13.75 12.26 0.27 0.20 
1nApo E GP 0.012 0.75 0.027 -0.033 0.13 0.11 
P - 0.023 0.031 0.014 0.113 0.12 0.11 
C 0.145* 0.108 0.206** 0.176* 0.12 0.11 
Apo AI Apo AI1 1nApo E 
*p < 0.05; **p < 0.01. 
“GP = grandparents, P = parent, C = child. 
including Apo AI : Apo AI1 and Apo AI : 1nApo 
E correlations, were homogeneous across all 
cohorts. The average correlation for Apo 
AI: Apo AI1 was r = 0.425, for Apo AI:lnApo 
E was r = 0.056, and for Apo AII:lnApo E was 
r = 0.080. It should be noted that the MC have 
a statistically significant Apo AI : 1nApo E corre- 
lation (1. = 0.145) and MC and FC have statisti- 
cally significant Apo AII:lnApo E correlations 
(MC: r = 0.206, FC: I = 0.176) while the other 
cohorts show no significant correlation between 
these traits. The homogeneity of covariance 
across generations or genders indicates that the 
relationship between apolipoprotein levels is 
stable throughout life and not influenced by 
gender differences. Also, homogeneity of covari- 
ante across cohorts implies that these bivariate 
distributions do not provide additional risk 
information beyond the information about 
high risk subgroups which is available from 
examining the univariate means and variances. 
Lipid and apolipoprotein covariation and 
correlation 
Characterizing the covariation and corre- 
lation between an individual’s apolipoprotein 
and lipid levels is of particular importance be- 
cause it reflects the relationship between levels 
of gene products and intermediate traits that are 
measures of lipid metabolism that may link 
genetic and environmental variation to vari- 
ation in CAD risk. The correlations (Table 7) 
between the apolipoproteins and lipids can be 
divided into two classes based on the average 
correlation across cohorts. The first class in- 
cludes those traits which were statistically sig- 
nificantly correlated, r > 0.2, and the second 
class includes those traits that are marginally 
correlated, r < 0.2. The traits involved in each 
class are consistent with known physiological 
relationships between the lipids and apolipo- 
proteins. The significantly correlated variables 
include HDL-C and the protein constituents of 
the HDL particle, Apo AI and Apo AII, with 
weighted average correlations of r = 0.714 and 
r = 0.309, respectively. Other members in the 
class of strongly correlated gene products and 
intermediate phenotypes include Total-C with 
each of the apolipoproteins and InTrig with 
1nApo E. The class of bivariate distributions 
with marginally significant correlations were of 
less interest, but still noteworthy, because 
specific cohorts that show deviations from the 
remaining cohorts may indicate qualities that 
characterize high or low risk profiles. This set 
of correlations included 1nTrig with Apo AI 
and with Apo AII, LDL-C with each of the 
apolipoproteins, and HDL-C 1nApo E. 
There are several instances where homogen- 
eity of variance (type (i) and (ii) outcomes) 
allowed us to make definite inferences about 
covariance differences between apolipoproteins 
and lipids across cohorts (Table 8). First, for 
females the covariances of 1nTrig with each of 
the apolipoproteins and HDL-C with each of 
the apolipoproteins Were homogeneous across 
generations. Second, MC and FC had homo- 
geneous covariances between Total-C, InTrig, 
or LDL-C and each of the apolipoproteins. 
Third, MPs and FPs showed similar magnitudes 
of covariation in their LDL-C: Apo AII, 
LDL-C : 1nApo E, and 1nTrig : 1nApo E distribu- 
tions. In contrast, there were significant differ- 
ences in 1nTrig: Apo AI1 covariation between 
MPs and FPs. The 1nTrig: Apo AI1 correlations 
in MPs and FPs were r = -0.050 and T = 
0.180, respectively. Also, between genders, 
MGPs and FGPs showed approximately equal 
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covariation in all lipid and apolipoprotein 
bivariate distributions, except HDL-C : Apo AI 
covariation which was significantly greater in 
MGPs than in FGPs. Given that the corre- 
lations between HDL-C and Apo AI are 
not very different (FGP: r = 0.750, MGP : r = 
0.787), it seems unlikely that the observed 
statistical significance is biologically relevant. 
In instances where heterogeneity of variance 
was demonstrated, the tests for homogeneity 
of correlation coefficients provided evidence 
for heterogeneity in Total-C: 1nApo E and 
HDL-C: 1nApo E correlation (type (iv) out- 
come) across generations in females and males, 
respectively. Across generations in females 
we found that FPs had a substantially stronger 
Total-C : 1nApo E correlation (FP : r = 0.303) 
than FC and FGPs (FC:r =0.201, FGP:r = 
0.071). Across generations in males, we 
found that MC had a significant, positive 
HDL-C : 1nApo E correlation (MC: r = 0.217) 
while MPs and MGPs had weak, negative corre- 
lations (MP:r = -0.111, MGP:r = -0.021). 
To summarize these results, we observed 
homogeneity of covariance (type (i)) or hom- 
ogeneity of correlation (type (iii)) among all six 
cohorts in the bivariate distributions of Total- 
C : Apo AI (weighted average r = 0.253), Total- 
C: Apo AI1 (weighted average r = 0.269), 
1nTrig : Apo AI (weighted average r = - 0.044), 
1nTrig: 1nApo E (weighted average r = 0.229), 
HDL-C : Apo AI1 (weighted average r = 0.309), 
LDL-C:Apo AI (weighted average r = 0.027), 
LDL-C: Apo AI1 (weighted average r = 0.165), 
and LDL-C: 1nApo E (weighted average r = 
0.150). In contrast we observed significant 
heterogeneity in HDL-C : Apo AI covariation 
between genders in grandparents, in 1nTrig : Apo 
AI1 covariation between genders in parents, 
in Total-C: 1nApo E correlations across gen- 
erations in females, and in HDL-C: 1nApo E 
correlations across generations in males. 
Summary of lipid and apolipoprotein covariances 
and correlations 
Table 9 presents a summary of the gener- 
ation and gender effects on the covariation and 
correlation between lipid and apolipoprotein 
traits. The table is separated into generation 
effects (lower triangle) and gender effects (upper 
triangle). The Y indicates a statistically signifi- 
cant difference across cohorts, the ‘?” indicates 
that variance and covariance differences are 
confounded, and the blanks indicate homogen- 
eity of covariance across cohorts. This table 
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illustrates that there were significant gener- 
ation effects and gender effects on lipid covari- 
ation in the Total-C : InTrig, Total-C : LDL-C, 
1nTrig : LDL-C, and HDL-C : LDL-C bivariate 
distributions. There were significant generation 
effects on the Total-C: 1nApo E and HDL- 
C: 1nApo E distributions and significant gender 
effects on HDL-C : Apo AI and 1nTrig : Apo AI1 
distributions. No generation or gender effects 
were found in any of the apolipoprotein covari- 
antes or correlations. Table 9 also illustrates 
that a substantial proportion of the bivariate 
distributions have confounded variance and 
covariance differences across cohorts. One 
method to resolve the confounded nature of 
these bivariate distributions is to examine the 
relationship between the correlation coefficients 
and the geometric means of the variances 
(i.e. the denominator of the correlation co- 
efficient) across cohorts., This method resolves 
approximately half of the confounded differ- 
ences across cohorts (data not shown) into 
variance dominated or covariance dominated 
difference in correlations across cohorts. The 
development of statistical procedures for test- 
ing covariance differences (exclusively) would 
eliminate this problem. 
relationships among traits. Defining the extent 
to which the levels of lipid and apolipoprotein 
traits are interrelated is therefore a means of 
identifying the sets of traits which may cumu- 
latively result in predisposition or resistance to 
CAD. Principal components analysis is one 
method for identifying the sets of covarying 
lipid and apolipoprotein traits. The eigenvalues 
and eigenvectors associated with the first two 
principal components are presented for each 
cohort in Fig. 3. The eigenvalues represent the 
variances of the principle components deter- 
mined by orthogonal weighted functions of the 
seven adjusted lipid and apolipoprotein vari- 
ables. The test results indicate that the eigen- 
values for both components were homogeneous 
across all strata. The first and second principal 
components combined explained approximately 
64% of the total sample variance in each cohort. 
Although there is no specific test for hetero- 
geneity of eigenvectors across strata, the magni- 
tude and direction of the eigenvector weightings 
for each principal component provide a profile 
for comparison (Fig. 3). 
Principal component analyses 
Since lipid metabolism is an integrated 
assemblage of lipid and apolipoprotein traits 
which function as a unit, the ability of the lipid 
metabolic pathway to respond to environ- 
mental changes depends upon the nature of the 
In all cohorts, the first principal component 
explained approximately 35% of the total co- 
hort variance. Figure 3(a) illustrates that the 
eigenvector weightings for the first component 
are approximately the same across cohorts ex- 
cept for FPs. In all cohorts except FPs, the first 
principal component was dominated by the 
positive weighting of Total-C, LDL-C, Apo AI, 
Apo AIL and HDL-C. In contrast, FPs had the 
most distinct profile in that LDL-C, Total-C, 
Table 9. Generation and gender effects on covariance correlation 
(Y = significant effect, ? = confounded variance-covariance effect, 
blank = no effect) 
Gender effect 
,TOTAL-C, InTRIG , HDL-C , LDL-C , APO AI ,APO All ,InAW E, 
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0.75 - (0) Eigenvalues 
A 2.45 mop; 
0.50 - &= 2.41 
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Fig. 3. (a) First prinicipal component. (b) Second principal component. 
and InTrig-in this rank order-were the domi- 
nant positive contributors in the eigenvector. 
The second principal component explained 
an additional 28% (approximately) of the total 
cohort variation. In this principal component 
[Fig. 3(b)] there is negative covariance be- 
tween HDL-C : InTrig, HDL-C : LDL-C, and 
1nTrig:Apo AI. The eigenvector weightings of 
this principal component [Fig. 3(b)] clearly sep- 
arates the six cohorts into two classes. The 
second component of MGPs, FGPs, and MPs 
show a positive association between Total-C, 
InTrig, LDL-C, and 1nApo E and a negative 
association with HDL-C, Apo AI, and Apo AII. 
FPs, MC, and FC have eigenvectors with an 
opposite orientation to the MGP, FGP, and MP 
type of eigenvector. Although the third through 
seventh principal components also exhibited 
heterogeneity across cohorts, they are not pre- 
sented here because, separately, they each rep- 
resent less than 15% of the multivariate 
variation. 
DISCUSSION 
Mean levels of lipids and apolipoproteins 
Our data agree with other investigations of 
the impact age and gender have on mean levels 
of measures of lipid metabolism [52-561. Be- 
tween genders, women tend to have higher 
concentrations of the molecules, such as 
HDL-C and Apo AI, associated with decreased 
risk to CAD and men tend to have higher levels 
of metabolites, such as Total-C and LDL-C 
associated with increased risk of CAD. In our 
study, we found only two exceptions to this 
pattern of gender differences: FC show substan- 
tially higher levels of LDL-C than MC and 
FGPs have higher levels of Total-C than MGPs. 
In the Bogalusa Heart Study, Freedman et al. 
[56] also report higher LDL-C concentrations in 
FC vs MC. Tyroler et al. [53] report that older 
females have higher Total-C levels than males of 
comparable age. 
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Age-associated increases in mean levels of 
lipid measures are well established [57] and may 
represent a metabolic drift as homeostatic con- 
trol mechanisms weaken with age [40,58]. In 
our study, the mean levels of the lipids and 
apolipoprotein levels, with the exception of Apo 
AII, dramatically increased across generations. 
This age-dependent rise in levels has also been 
demonstrated in longitudinal studies [58,59]. 
An age-dependent profile of lipid levels is most 
likely due to a combination of environmental 
(e.g. changes in diet and exercise) and biological 
factors (e.g. changes in the biological activity of 
gene products or hormone production associ- 
ated with aging). Biochemical studies indicate 
that the increase in total Total-C could be due 
to increased LDL-C production, increased 
VLDL-C production and decreased fractional 
clearance of LDL-C, or decreased LDL-C- 
receptor activity [60]. Further investigations are 
needed to determine the genetic and environ- 
mental causes of this age-dependent risk factor 
profile. 
Generation and gender specific variability 
Our results indicate that heterogeneity of 
variance across generation and gender is highly 
significant for the lipid traits but not for the 
apolipoprotein traits. There are at least four 
possible explanations for the variance differ- 
ences across cohorts: (i) differences in additive 
genetic variance, (ii) differences in environmen- 
tal variance, (iii) differences in gene by environ- 
ment interaction, and (iv) some combination of 
(i), (ii), and (iii) [45,46]. In other words, the 
differences in variation across cohorts will em- 
anate from external, internal, or interaction 
between internal and external forces. 
For a complex system such as lipid metab- 
olism there is a hierarchy associated with the 
metabolic network [6164]. We hypothesize that 
the different degree of heterogeneity of variance 
between lipids and apolipoproteins is due to 
their position within the hierarchy of biological 
macromolecules (e.g. intermediate traits vs gene 
products). We expect different susceptibilities to 
perturbation by environmental factors at differ- 
ent levels in the hierarchy [63,64]. Within this 
context, we would expect apolipoprotein levels 
to be less susceptible to perturbation by en- 
vironmental variation and more susceptible to 
perturbation by genetic variation. In contrast, 
interindividual differences in lipid levels are 
expected to depend more on gene by environ- 
ment interaction and environmental variation 
and less on genetic variation. The role of gene 
by environment interaction in determining phe- 
notypic variation has been well established in 
animal and plant genetics [47,48] but there has 
been very little recognition of the role that gene 
by environment interaction and possibly covari- 
ation may have on changes in phenotypic vari- 
ance during human development and senescence 
[65,66]. 
Given the hypothesis stated above, the ob- 
served increase in variation in lipid levels across 
generations could represent differential ex- 
posures to variation in diet, exercise, alcohol or 
cigarette consumption, and stress which each 
have effects on lipid metabolism. Children are 
expected to be exposed to a smaller range of 
environmental variations and therefore show 
less phenotypic variability. A fraction of the 
increased phenotypic variability in parents and 
grandparents may be due to the cumulative 
effects of exposures to environmental factors 
over a greater age range. In addition, the 
observed increase in lipid variation could 
be associated with differences in gene by 
environment interaction. 
Gender differences in lipid level variation may 
also be products of environmental and biologi- 
cal factors. Men and women commonly differ in 
their attention to diet and exercise as well as 
differential attraction to alcohol and cigarette 
consumption or stress related activities [67]. 
Also, gender-specific hormone production and 
gender-related differences in the homeostatic 
mechanisms underlying the metabolic systems 
could affect the metabolite variability in a par- 
ticular cohort [32-351. In this cross-sectional 
study, the significant heterogeneity between gen- 
ders in the parent generation could reasonably 
be explained by these biological and environ- 
mental differences. In contrast, the homogeneity 
of variance between MGPs and FGPs may be a 
product of selective survivorship in our sample. 
In the truncated sample used in these analyses, 
there were only 184 MGPs vs 242 FGPs. This 
ratio was approximately the same in the untrun- 
cated sample (i.e. 226 MGP, 331 FGP). The 
homogeneity of variance between MGPs and 
FGPs may also be due to diminishing sexual 
dimorphism. 
Generation and gender speciJc covariability 
It is widely accepted that changes in lipid 
levels with respect to age and gender are dis- 
criminators of high and low risk of CAD. The 
age and gender differences in the relationship 
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between lipid traits also has the potential to 
discriminate between high and low risk groups 
(Fig. 2). The bivariate correlations which were 
heterogeneous across strata represent a set of 
potential metabolic relationships which are 
associated with risk-especially, the correlation 
differences which are unique to the high risk age 
and gender groups, such as MPs, FGPs and 
MGPs. From our results we would predict that 
weak levels of 1nTrig: LDL-C, HDL-C : LDL-C, 
and HDL-C: 1nApo E covariation are associ- 
ated with increased risk of CAD. In contrast, 
strong, positive 1nTrig : LDL-C and HDL- 
C: 1nApo E correlations and strong, negative 
HDL-C : LDL-C correlations are associated 
with decreased risk. 
In general, our estimates of the correlations 
among lipids and apolipoproteins were in agree- 
ment with other studies [52-55,68,69]. The 
effects of gender and age differences on lipid 
correlations have been also demonstrated in 
several studies [54,68-701. These studies agree 
with our findings that there is no association 
between LDL-C and HDL-C levels in males but 
a significant negative association in females not 
taking hormones [54,68]. The gender and gener- 
ation differences in corrrelations may be due to 
similar or unknown environmental and/or bio- 
logical factors which affected the variance of 
these metabolites. However, it is important to 
note that differences in trait covariation across 
cohorts must be associated with differences 
in environmental, genetic, or gene by environ- 
ment covariation [45,71]. In other words, the 
pleiotropic effects of genes or environments 
must be different across cohorts [72]. For 
example, if smoking is associated with a 15% 
decrease in HDL-C levels and a 10% increase 
in LDL-C levels in MPs, then in MGPs 
smoking may only be associated with 5% de- 
crease in HDL-C levels and still a 10% increase 
in LDL-C levels. In genetic terms, a change or 
difference in genetic covariation is attributable 
to differences in pleiotropic effects across co- 
horts. In animal and plant genetics, many stud- 
ies have shown that pleiotropic relationships 
which increase reproductive fitness change to 
antagonistic pleiotropic relationships during the 
development of senescence [41,73,74]. This 
phenomena is especially relevant in the study 
of CAD since the relationship between LDL-C 
and HDL-C levels may positively influence re- 
productive fitness through sex hormone levels 
but during senescence the relationship between 
these cholesterols may shift to an antagonistic 
pleiotropic relationship. 
The principal component analyses sum- 
marizes the covariance and correlation differ- 
ences across cohorts. The striking similarity 
between the MGP’s, FGP’s and MP’s second 
principal components provides evidence that 
these individuals may be in the same risk cat- 
egory despite differences in their levels of the 
risk factor traits. The homogeneity of the eigen- 
values across cohorts indicates that there are 
similar partitions of the multivariate space of 
lipid metabolites even when the lipid and 
apolipoprotein levels, variances, and covari- 
antes are heterogeneous across cohorts. In other 
words, the homogeneity of the first and second 
principal component’s eigenvalues across strata 
suggests that distinct subspaces, such as a 
sphere or ellipsoid within a more complex three- 
dimensional space, may have their diameter or 
major axis (i.e. principal component) defined 
by several different functions of the individual 
variables (i.e. eigenvectors). One could hypoth- 
esize that these distinct and orthogonal sub- 
spaces are a consequence of the balance be- 
tween stabilizing (homeostatic) and adaptive 
(dynamic or kinetic) mechanisms which work 
independently to ensure viability of the organ- 
ism (within the context of the metabolic system 
under consideration) [25,61,63,64]. 
CONCLUSION 
Significant heterogeneity among cohorts in 
the second moments of the multivariate distri- 
bution of lipid metabolites suggests some guide- 
lines or at least cautions for future genetic 
and epidemiological studies. First, males and 
females should be analyzed separately. This is 
already a heuristic for many investigators when 
they are examining average differences in trait 
levels. Variance and covariance homogeneity 
across genders should be demonstrated before 
pooling males and females together to analyze 
primary hypotheses about causation. Second, 
the age window under analysis should be 
defined carefully with respect to the underlying 
question being asked, Third, the assumption of 
no age and gender effects on the mean and 
variance of a trait should be demonstrated 
before the trait is analyzed to determine if a 
single gene (measured or unmeasured) with a 
significant effect on trait levels is segregating in 
pedigrees. Regression to the age and gender 
mean of a large sample of pedigrees will not 
remove the heterogeneity observed in this study 
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but only distort it. Age and gender dependent 
penetrance functions in genetic analyses are 
required to deal with this problem. 
Although we have pointed out several in- 
stances where differences in the relationship 
between variables across cohorts may be im- 
portant to assessing risk of CAD, further studies 
are needed to evaluate the utility of variability 
and covariability in predicting risk. By examin- 
ing the variance and covariance profile of indi- 
viduals in different clinical subgroups with 
CAD, we hope to define the multivariate pro- 
files (i.e. means, variances, and covariances) 
which discriminate between subgroups in the 
population at large who have different levels of 
CAD risk. The current ability to measure an 
individual’s genotype (either at the DNA or 
protein product level) for genes involved in 
lipid metabolism may also help to discriminate 
between subgroups in the population who have 
different levels of CAD risk. Further studies 
are needed to identify and characterize the 
genotypes and environments responsible for 
heterogeneity in the multivariate profile of risk 
factors among gender and age specific strata of 
the population at large. 
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